Dianthus Therapeutics, Inc. (DNTH) SEC filings
DNTH SEC filings moved a median of +1.34% by the close. DNTH SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the DNTH overview →
60 measured DNTH SEC filing events.
Where these DNTH SEC filings landedvs 60 measured DNTH SEC filing reactions
| Middle 50% of DNTH SEC filing reactions | -1.63% to +4.44% |
|---|---|
| Median reaction (to close) | +1.34% |
| Measured reactions | 60 |
Point-in-time · zero look-ahead
Half of the 60 DNTH SEC filing events with a measured close landed between -1.63% and +4.44%; 62% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form S-3ASR Dianthus Therapeutics, | SEC filing · Form S-3ASR | +1.03% | +0.54% | |
| Form 10-Q Dianthus Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.81% | +2.38% | |
| Form 8-K Dianthus Therapeutics, For: Aug 04 | SEC filing · Form 8-K | +1.81% | +2.38% | |
| Form 8-K Dianthus Therapeutics, For: Jun 12 | SEC filing · Form 8-K | +2.54% | +6.35% | |
| Form 8-K Dianthus Therapeutics, For: May 21 | SEC filing · Form 8-K | -0.62% | -0.82% | |
| Form 10-Q Dianthus Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.38% | -1.51% | |
| Form 8-K Dianthus Therapeutics, For: May 05 | SEC filing · Form 8-K | -1.38% | -1.51% | |
| Form ARS Dianthus Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.84% | -2.42% | |
| Form DEF 14A Dianthus Therapeutics, For: May 21 | SEC filing · Form DEF | -0.84% | -2.42% | |
| Form DEFA14A Dianthus Therapeutics, | SEC filing · Form DEFA14A | -0.84% | -2.42% | |
| Form 8-K Dianthus Therapeutics, For: Mar 26 | SEC filing · Form 8-K | +0.81% | +3.09% | |
| Form 8-K Dianthus Therapeutics, For: Mar 10 | SEC filing · Form 8-K | -3.27% | -6.09% | |
| Form S-3MEF Dianthus Therapeutics, | SEC filing · Form S-3MEF | -1.33% | -1.17% | |
| Form 10-K Dianthus Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +6.11% | +1.32% | |
| Form 8-K Dianthus Therapeutics, For: Mar 09 | SEC filing · Form 8-K | +6.11% | +1.32% | |
| Form S-8 Dianthus Therapeutics, | SEC filing · Form S-8 | +6.11% | +1.32% | |
| Form EFFECT Dianthus Therapeutics, | SEC filing · Form EFFECT | -0.04% | -0.13% | |
| Form S-3 Dianthus Therapeutics, | SEC filing · Form S-3 | -0.41% | +2.99% | |
| Form 8-K Dianthus Therapeutics, For: Jan 12 | SEC filing · Form 8-K | -2.06% | +2.14% | |
| Form 10-Q Dianthus Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +2.51% | +7.62% | |
| Form 8-K Dianthus Therapeutics, For: Nov 05 | SEC filing · Form 8-K | +2.51% | +7.62% | |
| Form 8-K Dianthus Therapeutics, For: Nov 03 | SEC filing · Form 8-K | -0.39% | +1.37% | |
| Form 8-K Dianthus Therapeutics, For: Oct 16 | SEC filing · Form 8-K | +1.54% | -1.99% | |
| Form 8-K Dianthus Therapeutics, For: Sep 09 | SEC filing · Form 8-K | +2.43% | +2.38% | |
| Form 8-K Dianthus Therapeutics, For: Sep 08 | SEC filing · Form 8-K | +1.48% | +27.05% | |
| Form 10-Q Dianthus Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.47% | -1.26% | |
| Form 8-K Dianthus Therapeutics, For: Aug 07 | SEC filing · Form 8-K | -1.47% | -1.26% | |
| Form 8-K Dianthus Therapeutics, For: May 22 | SEC filing · Form 8-K | +1.21% | +3.80% | |
| Form 10-Q Dianthus Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +2.22% | -3.68% | |
| Form 8-K Dianthus Therapeutics, For: May 12 | SEC filing · Form 8-K | +2.22% | -3.68% | |
| Form ARS Dianthus Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.95% | +12.02% | |
| Form DEF 14A Dianthus Therapeutics, For: May 22 | SEC filing · Form DEF | +0.95% | +12.02% | |
| Form DEFA14A Dianthus Therapeutics, | SEC filing · Form DEFA14A | +0.95% | +12.02% | |
| Form 10-K Dianthus Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +7.09% | +0.23% | |
| Form 8-K Dianthus Therapeutics, For: Mar 11 | SEC filing · Form 8-K | +7.09% | +0.23% | |
| Form S-8 Dianthus Therapeutics, | SEC filing · Form S-8 | +7.09% | +0.23% | |
| Form 8-K Dianthus Therapeutics, For: Mar 04 | SEC filing · Form 8-K | +7.02% | +15.01% | |
| Form 8-K Dianthus Therapeutics, For: Dec 12 | SEC filing · Form 8-K | +0.71% | +3.16% | |
| Form 10-Q Dianthus Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -3.24% | -9.89% | |
| Form 8-K Dianthus Therapeutics, For: Nov 07 | SEC filing · Form 8-K | -3.24% | -9.89% | |
| Form RW Dianthus Therapeutics, | SEC filing · Form RW | +0.57% | -0.18% | |
| Form EFFECT Dianthus Therapeutics, | SEC filing · Form EFFECT | +0.00% | +1.58% | |
| Form S-3 Dianthus Therapeutics, | SEC filing · Form S-3 | +1.91% | +2.94% | |
| Form 8-K Dianthus Therapeutics, For: Sep 16 | SEC filing · Form 8-K | -0.42% | -2.77% | |
| Form 10-Q Dianthus Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.70% | +1.85% | |
| Form 8-K Dianthus Therapeutics, For: Aug 08 | SEC filing · Form 8-K | -1.70% | +1.85% | |
| Form S-8 Dianthus Therapeutics, | SEC filing · Form S-8 | -1.70% | +1.85% | |
| Form 8-K Dianthus Therapeutics, For: Jun 06 | SEC filing · Form 8-K | +0.27% | -6.52% | |
| Form 8-K Dianthus Therapeutics, For: May 23 | SEC filing · Form 8-K | +0.00% | +4.28% | |
| Form 10-Q Dianthus Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -3.17% | -8.27% | |
| Form 8-K Dianthus Therapeutics, For: May 09 | SEC filing · Form 8-K | -3.17% | -8.27% | |
| Form ARS Dianthus Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.00% | +4.90% | |
| Form DEF 14A Dianthus Therapeutics, For: May 23 | SEC filing · Form DEF | +0.00% | +4.90% | |
| Form DEFA14A Dianthus Therapeutics, | SEC filing · Form DEFA14A | +0.00% | +4.90% | |
| Form EFFECT Dianthus Therapeutics, | SEC filing · Form EFFECT | +0.00% | -3.63% | |
| Form 10-K Dianthus Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +11.95% | +9.20% | |
| Form 8-K Dianthus Therapeutics, For: Mar 21 | SEC filing · Form 8-K | +11.95% | +9.20% | |
| Form S-1/A Dianthus Therapeutics, | SEC filing · Form S-1 | +11.95% | +9.20% | |
| Form S-8 Dianthus Therapeutics, | SEC filing · Form S-8 | +11.95% | +9.20% | |
| Form S-1/A Dianthus Therapeutics, | SEC filing · Form S-1 | -7.83% | -3.33% |
Keep exploring
More DNTH: earnings → · analyst actions → · DNTH overview →